<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<rss version="2.0">
    <channel>
        <title>NPRE seminars</title>
        <link>http://illinois.edu/calendar/list/4035</link>
        <description>Used for Nuclear, Plasma, and Radiological Engineering seminars.</description>
        <item>
            <title>UIUC - MGH Seminar Series-Neil Vasdev, PhD, Massachusetts General Hospital</title>
            <link>http://illinois.edu/calendar/detail/4035/32706485</link>
            <category>UIUC - MGH Seminar Series</category>
            <guid isPermaLink="true">http://illinois.edu/calendar/detail/4035/32706485</guid>
            <pubDate>Fri, 26 Jun 2015 12:00:00 CDT</pubDate>
            <description>&lt;p style="text-align: center;"&gt;&lt;strong&gt;"Cutting-edge radiochemical methods and technologies for human PET imaging"&lt;/strong&gt;&lt;/p&gt;
&lt;p style="text-align: center;"&gt;Neil Vasdev, Ph.D.&lt;/p&gt;
&lt;p style="text-align: center;"&gt;Director of Radiochemistry, Massachusetts General Hospital&lt;/p&gt;
&lt;p style="text-align: center;"&gt;Associate Professor, Harvard Medical School&lt;/p&gt;
&lt;p&gt;This presentation will focus on some non-traditional approaches to prepare PET radiopharmaceuticals for new targets, and aims to show the intricacies of developing PET radiopharmaceuticals from "bench to bedside". Specifically, cutting-edge approaches and technologies for imaging the dopaminergic pathway with PET, as well as our recent work to expand beyond the &amp;ldquo;amyloid cascade hypothesis&amp;rdquo; of Alzheimer&amp;rsquo;s disease, including tauopathies, will be presented. Several of the neuroimaging agents have also been applied as oncology probes. Translating labeled compounds to PET radiopharmaceuticals and our aspiration to work towards the ultimate, albeit impossible, goal in the field: to radiolabel virtually any compound for PET will be raised as points for discussion.&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;</description>
        </item>
    </channel>
</rss>